Vincerx Pharma, Inc.
VINCDelisted Apr 28, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001796129
Vincerx Pharma, Inc. was delisted on Apr 28, 2025; its insiders filed their last Form 4 on Aug 14, 2024; 14 institutions reported holding it in 13F filings for Q1 2025, worth $116.8K in total; no superinvestor held it.
Q2 2022 vs. Q1 2022
How the institutions holding Vincerx Pharma, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 65 | 2 | 49 | −14 |
| Shares | 16.3M | 21.1K | 13.9M | −2.31M (−14.2%) |
| Value | $65.1M | $85.0K | $18.4M | −$46.6M (−71.7%) |
2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (8)
Institutions that held Vincerx Pharma, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| ExodusPoint Capital Management, LP | 100,103 | $132.0K | 0.00% |
| Ergoteles LLC | 80,700 | $107.0K | 0.00% |
| Acadian Asset Management LLC | 24,706 | $33.0K | 0.00% |
| Qube Research & Technologies Ltd | 17,326 | $23.0K | 0.00% |
| RBF Capital, LLC | 11,654 | $15.0K | 0.00% |
| Point72 Hong Kong Ltd | 707 | $1.00K | 0.00% |
| Credit Suisse AG | 9 | $0 | 0.00% |
| Advisor Group Holdings, Inc. | 291 | $0 | 0.00% |
Sold out (22)
Institutions that held Vincerx Pharma, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Deerfield Management Company, L.P. (Series C) | 1,379,310 | $5.52M |
| Russell Investments Group, Ltd. | 226,931 | $906.0K |
| Bank of Montreal | 84,131 | $332.0K |
| Bank of New York Mellon Corp | 59,434 | $238.0K |
| Trexquant Investment LP | 45,497 | $182.0K |
| Nuveen Asset Management, LLC | 40,474 | $173.0K |
| J. Goldman & Co LP | 43,101 | $172.0K |
| Charles Schwab Investment Management Inc | 39,707 | $159.0K |
| Veritable, L.P. | 29,087 | $116.0K |
| Hudson Bay Capital Management LP | 14,323 | $57.0K |
| Rhumbline Advisers | 13,307 | $53.0K |
| Jump Financial, LLC | 12,580 | $50.0K |
| Deutsche Bank AG | 10,054 | $41.0K |
| American International Group, Inc. | 8,157 | $33.0K |
| JPMorgan Chase & Co | 7,705 | $31.0K |
| California State Teachers Retirement System | 7,152 | $29.0K |
| Allspring Global Investments Holdings, LLC | 7,285 | $29.0K |
| STRS Ohio | 3,000 | $12.0K |
| Amalgamated Bank | 2,679 | $11.0K |
| Royal Bank of Canada | 1,009 | $4.00K |
| Ameritas Investment Partners, Inc. | 1,000 | $4.00K |
| FMR LLC | 459 | $2.00K |
Not filed for Q2 2022 yet (2)
Institutions that held Vincerx Pharma, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Parametric Portfolio Associates LLC | 18,405 | $74.0K |
| Amalgamated Financial Corp. | 2,679 | $11.0K |